Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.950
-0.010 (-0.51%)
At close: Apr 28, 2026, 4:00 PM EDT
1.960
+0.010 (0.51%)
Pre-market: Apr 29, 2026, 4:08 AM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $326.48 million as of April 28, 2026. Its market cap has increased by 10,820.00% in one year.
Market Cap
326.48M
Enterprise Value
193.16M
1-Year Change
10,820.00%
Ranking
Category
Stock Price
$1.95
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $326.48M, an increase of 334.91%. That is a compound annual growth rate of 34.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 328.15M | -6.28% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 363.70M |
| YD Bio | 361.44M |
| Monopar Therapeutics | 353.55M |
| Nautilus Biotechnology | 351.22M |
| Ovid Therapeutics | 348.15M |
| Bicycle Therapeutics | 341.56M |
| Compass Therapeutics | 340.37M |
| Greenwich LifeSciences | 339.99M |